Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.2 EUR | +0.41% |
|
-0.81% | +33.70% |
06-20 | Berenberg Lifts Price Target on Lonza Group, Maintains Buy Recommendation | MT |
05-14 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- Sales forecast by analysts have been recently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 38.77 and 30.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+33.70% | 38.48B | - | ||
+34.14% | 51.12B | B- | ||
-6.54% | 39.4B | B | ||
+12.62% | 26.36B | B- | ||
-12.11% | 26.22B | C | ||
-13.43% | 20.96B | B | ||
+43.73% | 14.02B | B+ | ||
+31.81% | 12.49B | C+ | ||
-4.54% | 11.61B | B+ | ||
-10.49% | 10.9B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LONN Stock
- LO3A Stock
- Ratings Lonza Group AG